A 17% rise in deaths linked to antibiotic-resistant superbugs in England has sparked urgent concerns about the growing threat of antimicrobial resistance. Official figures released by the UK Health Security Agency reveal a disturbing trend, with an increasing number of people acquiring infections that are resistant to frontline antibiotics.
But here's where it gets controversial: the rise in private prescriptions for antibiotics, which accounted for 22% of all dispensed antibiotics in 2024, is partly attributed to the Pharmacy First scheme. This flagship policy, implemented by Rishi Sunak's government, allows patients to obtain antibiotics for common illnesses without seeing a GP. The question arises: is this shift in prescribing patterns contributing to the rise in resistance?
"Antibiotic resistance is a grave health threat," warns Prof Susan Hopkins, CEO of UKHSA. "More people are facing infections that antibiotics can't effectively treat, putting them at risk of severe illness and even death. Our poorest communities are hit the hardest."
The emergence of drug-resistant strains is a natural selection process. Whenever antibiotics are used, some bacteria survive and multiply, leading to transmission. Limiting antibiotic use to essential cases is crucial to combat resistance, which could cause up to 10 million deaths annually worldwide by 2050.
Surveillance data for 2024 shows an average of nearly 400 newly reported antibiotic-resistant infection cases each week. Bacteraemia cases, a life-threatening bacterial blood infection, rose by 9.3% from 2023 to 2024, with an estimated 17% increase in deaths among those with resistant infections.
While antibiotic use in NHS primary care decreased between 2019 and 2024, private dispensing in community pharmacies more than doubled. Overall, primary care antibiotic use across the NHS and private sector rose by 10.7% over five years.
"It's encouraging to see antibiotic use fall within the NHS in England, but we must accelerate this progress," Hopkins emphasizes. "Remember, antibiotics should only be taken as directed by a healthcare professional. Do not save or share them, and bring any leftovers to a pharmacy for safe disposal."
The UKHSA data provides insights into the Pharmacy First scheme, designed to free up GPs for more complex cases. It allows treatment of seven common conditions at pharmacies, which supply antibiotics in 45% to 85% of consultations, depending on the condition. However, the UKHSA report cautions that this increase in antibiotic supply should be interpreted carefully within the broader context of patient care access.
And this is the part most people miss: the Pharmacy First scheme follows established Nice guidance on appropriate prescribing. So, is it really contributing to the rise in resistance, or is it a necessary step to manage the demand for healthcare services?
What do you think? Is the Pharmacy First scheme a necessary evil, or a dangerous step towards increased antibiotic resistance? Share your thoughts in the comments below!
